Barbara Bodem
Board Member
Biomarin Pharmaceutical Inc (BMRN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barbara Bodem
Barbara Bodem is recorded as Board Member at Biomarin Pharmaceutical Inc (BMRN). Biomarin Pharmaceutical Inc reported in an 8-K filed December 20, 2023 that Barbara Bodem was appointed independent director, effective December 27, 2023.
“On December 20, 2023, the size of the Board was expanded from 12 to 15 members in order to allow for the Board to appoint each of Ms. Bodem, Dr. Countouriotis and Mr. Enyedy to serve as a member of the Board, effective on December 27, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara W. Bodem Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.